JP2010508365A5 - - Google Patents

Download PDF

Info

Publication number
JP2010508365A5
JP2010508365A5 JP2009535569A JP2009535569A JP2010508365A5 JP 2010508365 A5 JP2010508365 A5 JP 2010508365A5 JP 2009535569 A JP2009535569 A JP 2009535569A JP 2009535569 A JP2009535569 A JP 2009535569A JP 2010508365 A5 JP2010508365 A5 JP 2010508365A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
csf
subject
pneumonia
fungal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009535569A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010508365A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2007/050161 external-priority patent/WO2008052567A2/en
Publication of JP2010508365A publication Critical patent/JP2010508365A/ja
Publication of JP2010508365A5 publication Critical patent/JP2010508365A5/ja
Pending legal-status Critical Current

Links

JP2009535569A 2006-11-03 2007-11-02 顆粒球マクロファージコロニー刺激因子を投与することによる肺の宿主防御の増強 Pending JP2010508365A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86419006P 2006-11-03 2006-11-03
US94751107P 2007-07-02 2007-07-02
PCT/DK2007/050161 WO2008052567A2 (en) 2006-11-03 2007-11-02 Enhancing pulmonary host defense via administration of granulocyte-macrophage colony stimulating factor

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013198117A Division JP2014028839A (ja) 2006-11-03 2013-09-25 顆粒球マクロファージコロニー刺激因子を投与することによる肺の宿主防御の増強

Publications (2)

Publication Number Publication Date
JP2010508365A JP2010508365A (ja) 2010-03-18
JP2010508365A5 true JP2010508365A5 (enExample) 2010-12-24

Family

ID=39344625

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009535569A Pending JP2010508365A (ja) 2006-11-03 2007-11-02 顆粒球マクロファージコロニー刺激因子を投与することによる肺の宿主防御の増強
JP2013198117A Pending JP2014028839A (ja) 2006-11-03 2013-09-25 顆粒球マクロファージコロニー刺激因子を投与することによる肺の宿主防御の増強
JP2015204558A Active JP6001151B2 (ja) 2006-11-03 2015-10-16 顆粒球マクロファージコロニー刺激因子を投与することによる肺の宿主防御の増強

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013198117A Pending JP2014028839A (ja) 2006-11-03 2013-09-25 顆粒球マクロファージコロニー刺激因子を投与することによる肺の宿主防御の増強
JP2015204558A Active JP6001151B2 (ja) 2006-11-03 2015-10-16 顆粒球マクロファージコロニー刺激因子を投与することによる肺の宿主防御の増強

Country Status (8)

Country Link
US (1) US20100015217A1 (enExample)
EP (1) EP2094290B1 (enExample)
JP (3) JP2010508365A (enExample)
AU (1) AU2007315402B2 (enExample)
BR (1) BRPI0717958B8 (enExample)
CA (1) CA2668292C (enExample)
MX (1) MX2009004802A (enExample)
WO (1) WO2008052567A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008116470A1 (en) * 2007-03-26 2008-10-02 Drugrecure Aps Enhancing pulmonary host defence via administration of granulocyte- colony stimulating factor
EP2688583A4 (en) 2011-03-22 2014-10-29 Univ Texas PROTECTION AGAINST INFLUENZA INFECTIONS BY THE GRANULOCYTE MACROPHAGENCOLONIA STIMULATING FACTOR
EP2694093B1 (en) * 2011-04-07 2018-03-21 Reponex Pharmaceuticals ApS Granulocyte-macrophage colony stimulating factor for enhancing pulmonary host defense in acute and chronic radiation syndrome, therapeutic radiation intervention and cancer therapy
JP2014529614A (ja) * 2011-08-29 2014-11-13 トリフォイリウム・エピエス 放射線により誘発されるまたは化学療法により誘発される肺機能不全の治療または予防のための組成物および方法
EP2850176B1 (en) * 2012-05-18 2019-01-16 Syracuse University Controlling pseudomonas aeruginosa persister cells with gm-csf
EP2877199A1 (en) * 2012-07-20 2015-06-03 Trifoilium ApS Granulocyte-macrophage colony-stimulating factor for the treatment of bronchial asthma
WO2014096032A1 (en) * 2012-12-18 2014-06-26 Trifoilium Aps Gm-csf for treatment of chronic sinusitis
WO2014128173A1 (en) 2013-02-20 2014-08-28 Trifoilium Aps Gm-csf for treatment of chronic oral mucositis
WO2015110536A1 (en) * 2014-01-22 2015-07-30 Reponex Pharmaceuticals Aps Granulocyte-macrophage colony-stimulating factor for the treatment and prevention of severe forms of bronchial asthma
US20170035850A1 (en) * 2014-03-07 2017-02-09 Reponex Pharmaceuticals Aps Compositions for treating lung infections by airway administration
JP2017524655A (ja) * 2014-05-23 2017-08-31 レポネックス・ファーマシューティカルズ・エーピーエス 創傷の治癒を促進するための組成物
EP3171887A1 (en) 2014-07-24 2017-05-31 Reponex Pharmaceuticals APS Compositions comprising granulocyte-macrophage colony-stimulating factor for the treatment of inflammatory bowel disease
JP7545893B2 (ja) * 2017-10-16 2024-09-05 ドラッグレキュア エーピーエス 難治性非結核性マイコバクテリア感染症の治療のためのｇｍ－ｃｓｆ
WO2021188883A1 (en) * 2020-03-20 2021-09-23 The Regents Of The University Of Colorado, A Body Corporate Methods and compositions for the treatment of viral disease using granulocyte-macrophage colony-stimulating factor (gm-csf)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4501728A (en) * 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US5391485A (en) * 1985-08-06 1995-02-21 Immunex Corporation DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues
US5162111A (en) * 1986-07-30 1992-11-10 Grabstein Kenneth H Treatment of bacterial diseases with granulocyte-macrophage colony stimulating factor
US4837028A (en) * 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US9269067B2 (en) * 2002-04-04 2016-02-23 Altisource Solutions S.À.R.L. Method and apparatus for providing selective access to information
US7512585B2 (en) 2002-07-11 2009-03-31 Oracle International Corporation Support for multiple mechanisms for accessing data stores

Similar Documents

Publication Publication Date Title
JP2010508365A5 (enExample)
JP2014028839A5 (enExample)
Wenzler et al. Inhaled antibiotics for gram-negative respiratory infections
Dhanani et al. Fundamentals of aerosol therapy in critical care
Zarogoulidis et al. Clinical experimentation with aerosol antibiotics: current and future methods of administration
Rubin Air and soul: the science and application of aerosol therapy
CN102325532B (zh) 用于减轻肺部炎症的左氧氟沙星吸入剂
WO2008052567A3 (en) Enhancing pulmonary host defense via administration of granulocyte-macrophage colony stimulating factor
JP2011520911A5 (enExample)
JP2012503668A5 (enExample)
JP2016513688A5 (enExample)
MX346244B (es) Composiciones de vancomicina en polvo seco y metodos asociados.
Grasemann et al. Cystic fibrosis lung disease: the role of nitric oxide
JP2001505553A (ja) ウリジン三リン酸および関連化合物で気管支炎を治療する方法
Sanjar et al. Treating systemic diseases via the lung
JP2014523909A (ja) 人工呼吸器関連肺炎（ｖａｐ）及び人工呼吸器関連気管（ｖａｔ）気管支炎の治療のためのアミカシンとホスホマイシンの組み合わせの製剤並びに方法及びシステム
JP2008516991A5 (enExample)
CN103735335B (zh) 一种金黄色葡萄球菌肺炎模型的建立方法
JP2008502699A5 (enExample)
Debnath et al. Status of inhalable antimicrobial agents for lung infection: progress and prospects
JP2008502698A5 (enExample)
JP2014529614A5 (enExample)
RU2014111818A (ru) Композиции и способы для лечения или предупреждения легочной дисфункции, вызываемой лучевой терапией или химиотерапией
CN109771397B (zh) 通过乳糖微粉预沉积改良肺部吸入用药的设备集成及方法
JP2013522295A5 (enExample)